Skip to main content
SpringerLink
Log in
Palgrave Macmillan
Book cover

Global Pharmaceutical Policy

  • Book
  • © 2020

Overview

Editors:
  1. Zaheer-Ud-Din Babar

    1. Centre for Pharmaceutical Policy and Practice Research, University of Huddersfield, Huddersfield, UK

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • The only text available today which provides an up to date account of international pharmaceutical policy research
  • Analyses the most relevant areas that may impact on the quality use of medicines and ultimately the health of populations
  • Fills a significant gap in the literature by offering a comprehensive analysis of pharmaceutical policy from a global point of view
  • Essential and timely resource for funders, policy makers, researchers and academics involved in research on pharmaceutical policy or involved in the teaching of pharmacy or medicine

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (14 chapters)

  1. Front Matter

    Pages i-xviii
    Download chapter PDF

  2. Medicines Safety in the Globalized Context

    • Rabia Hussain, Mohamed Azmi Hassali, Zaheer-Ud-Din Babar
    Pages 1-28

  3. Managing the Pharmaceutical Supply Chain—To Sustainability and Beyond

    • Liz Breen, Marina Papalexi, Ying Xie
    Pages 29-52

  4. Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy

    • Mohamed Izham Mohamed Ibrahim, Ahmed Awaisu
    Pages 53-72

  5. Global Access to Cancer Medicines

    • Hye-Young Kwon, Yujeong Kim
    Pages 73-97

  6. Medicines Pricing: Limitations of Existing Policies and New Models

    • Sabine Vogler
    Pages 99-137

  7. Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014 and 2019

    • Iram Malik, Muhammad Atif, Shane L. Scahill, Zaheer-Ud-Din Babar
    Pages 139-175

  8. Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components

    • Daniela Moye-Holz, Anahí Dreser, Octavio Gómez-Dantés, Veronika J. Wirtz
    Pages 177-222

  9. Access to Medicines: Case Studies from Russia and Kyrgyzstan

    • Liliya Eugenevna Ziganshina, Chinara M. Razzakova, Syed Shahzad Hasan, Zaheer-Ud-Din Babar
    Pages 223-246

  10. Access and Use of Medicines in Ukraine

    • Grintsova Olga, Zaheer-Ud-Din Babar
    Pages 247-260

  11. Public Participation in Access to Medicines

    • Sofia Crisóstomo, Filipa Alves da Costa
    Pages 261-291

  12. Pharmaceutical Policy and Practice Research: A Review of Studies in China

    • Caijun Yang, Amna Saeed, Khezar Hayat, Krizzia-Mae Lambojon, Ali Hassan Gillani, Yu Fang
    Pages 293-308

  13. Access to Vaccines and Immunization Programme

    • Suthira Taychakhoonavudh
    Pages 309-330

  14. Global Antibiotics Use and Resistance

    • Mamoon Aldeyab, José-María López-Lozano, Ian M. Gould
    Pages 331-344

  15. Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider

    • Zaheer-Ud-Din Babar, Shane L. Scahill
    Pages 345-365
Back to top

Keywords

About this book

Medicines are vital in improving patient health outcomes and pharmaceutical policy is a fundamental component of any health system. However, the global pharmaceutical policy is ever-evolving and data and quality ‘research-based information’ in this field are scarce. This book fills this gap and provides up-to-date empirical information and evidence-based synthesis. It focuses on pertinent key issues in global pharmaceutical policy including medicines safety, generic medicines, pharmaceutical supply chain, medicines financing, access and affordability of medicines, rational use of medicines, pharmacy health services research and access to vaccines and biological products. Featuring policy case studies from varied countries such as Mexico, Russia, China, Kyrgyzstan, and Pakistan, this book comprises a valuable and comprehensive resource for students, funders, policymakers, academics, and researchers interested in this field.

Reviews


Editors and Affiliations

  • Centre for Pharmaceutical Policy and Practice Research, University of Huddersfield, Huddersfield, UK

    Zaheer-Ud-Din Babar

About the editor

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of the Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He has an in-depth understanding of global health, pharmacy systems and pharmaceutical policy and has worked in Malaysia, New Zealand, Pakistan and the UK.

Bibliographic Information

  • Book Title: Global Pharmaceutical Policy

  • Editors: Zaheer-Ud-Din Babar

  • DOI: https://doi.org/10.1007/978-981-15-2724-1

  • Publisher: Palgrave Macmillan Singapore

  • eBook Packages: Social Sciences, Social Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s) 2020

  • Hardcover ISBN: 978-981-15-2723-4Published: 16 June 2020

  • Softcover ISBN: 978-981-15-2726-5Published: 16 June 2021

  • eBook ISBN: 978-981-15-2724-1Published: 15 June 2020

  • Edition Number: 1

  • Number of Pages: XVIII, 365

  • Number of Illustrations: 14 b/w illustrations

  • Topics: Sociology, general, Medical Sociology, Pharmacology/Toxicology, Health Policy

Publish with us

Policies and ethics

Back to top

Search

Navigation